Abstract
Demyelinating diseases were described in patients receiving anti-TNF agents. Optic neuritis (ON) induced by TNF blockers was already described in 22 cases in the literature. In this article, the authors report a 53-year-old woman with refractory rheumatoid arthritis that developed neuritis optica after the fourth dose of infliximab and had a good outcome after anti-TNF withdrawal, associated with glucocorticoid treatment. In addition, the previous cases of ON induced by anti-TNF agents were reviewed.
References
Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsiks P et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 36:1681–1690
Furst DE (2010) The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 39:327–346
van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531–1534
Thomas CW Jr, Weinshenker BG, Sandborn WJ (2004) Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn’s disease. Inflamm Bowel Dis 10:28–31
Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429–1434
Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869
Foroozan R, Buono LM, Sergott RC, Savino PJ (2002) Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 120:985–987
Mejico LJ (2004) Infliximab-associated retrobulbar optic neuritis. Arch Ophthalmol 122:793–794
Strong BY, Erny BC, Herzenberg H, Razzeca KJ (2004) Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease. Ann Intern Med 140:W34
Chan JW, Castellanos A (2010) Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol 248:283–287
Felekis T, Katsanos K, Christodoulou D, Asproudis I, Tsianos EV (2009) Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn’s disease. J Crohns Colitis 3:212–214
Ouakaa-Kchaou A, Gargouri D, Trojet S, Hefaiedh R, Elloumi H, Kochlef A, Kilani A, Romani M, Kharrat J, Ghorbel A (2009) Retrobulbar optic neuritis associated with infliximab in a patient with Crohn’s disease. J Crohns Colitis 3:131–133
Pikkel J (2008) Possible link between infliximab and optic neuritis. Isr Med Assoc J 10:477–478
Hejazi R, Colombel JF, Peyrin-Biroulet L (2008) Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis. Gastroenterol Clin Biol 32:162–163
Mumoli N, Niccoli G, Scazzeri F, Picchietti S, Greco A, Cei M (2007) Infliximab-induced retrobulbar optic neuritis. QJM 100:531
Simsek I, Erdem H, Pay S, Sobaci G, Dinc A (2007) Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 66:1255–1258
Bidaguren A, Müller-Thyssen A, Blanco A, Mendicute J, Ubeda M (2007) Retrobulbar optic neuritis associated with Infliximab. Arch Soc Esp Oftalmol 82:109–112
Tran TH, Milea D, Cassoux N, Bodaghi B, Bourgeois P, LeHoang P (2005) Optic neuritis associated with infliximab. J Fr Ophtalmol 28:201–204
Rebolleda G (2004) Optic neuritis and infliximab. Arch Soc Esp Oftalmol 79:591
Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm 18:475–481
Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977–1983
Acknowledgments
Carvalho JF received grants from the Federico Foundation and CNPq (300665/2009-1).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Faillace, C., de Almeida, J.R.M. & de Carvalho, J.F. Optic neuritis after infliximab therapy. Rheumatol Int 33, 1101–1103 (2013). https://doi.org/10.1007/s00296-011-2316-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2316-x